180 related articles for article (PubMed ID: 21685545)
1. Antiviral effects of interferon-β are enhanced in the absence of the translational suppressor 4E-BP1 in myocarditis induced by Coxsackievirus B3.
Burke JD; Sonenberg N; Platanias LC; Fish EN
Antivir Ther; 2011; 16(4):577-84. PubMed ID: 21685545
[TBL] [Abstract][Full Text] [Related]
2. Combination of RNA interference and virus receptor trap exerts additive antiviral activity in coxsackievirus B3-induced myocarditis in mice.
Stein EA; Pinkert S; Becher PM; Geisler A; Zeichhardt H; Klopfleisch R; Poller W; Tschöpe C; Lassner D; Fechner H; Kurreck J
J Infect Dis; 2015 Feb; 211(4):613-22. PubMed ID: 25193982
[TBL] [Abstract][Full Text] [Related]
3. Early Treatment of Coxsackievirus B3-Infected Animals With Soluble Coxsackievirus-Adenovirus Receptor Inhibits Development of Chronic Coxsackievirus B3 Cardiomyopathy.
Pinkert S; Dieringer B; Klopfleisch R; Savvatis K; Van Linthout S; Pryshliak M; Tschöpe C; Klingel K; Kurreck J; Beling A; Fechner H
Circ Heart Fail; 2019 Nov; 12(11):e005250. PubMed ID: 31718319
[TBL] [Abstract][Full Text] [Related]
4. Lithium chloride confers protection against viral myocarditis via suppression of coxsackievirus B3 virus replication.
Zhao Y; Yan K; Wang Y; Cai J; Wei L; Li S; Xu W; Li M
Microb Pathog; 2020 Jul; 144():104169. PubMed ID: 32205210
[TBL] [Abstract][Full Text] [Related]
5.
Lee YG; Park JH; Jeon ES; Kim JH; Lim BK
J Microbiol Biotechnol; 2016 Nov; 26(11):2012-2018. PubMed ID: 27558433
[TBL] [Abstract][Full Text] [Related]
6. Protective effects of 20(s)-protopanaxtriol on viral myocarditis infected by coxsackievirus B3.
Wang X; Wang Y; Ren Z; Qian C; Li Y; Wang Q; Zhang Y; Zheng L; Jiang J; Yang C; Wang D; Zhang Y; Fan J; Wang Y
Pathobiology; 2012; 79(6):285-9. PubMed ID: 22688124
[TBL] [Abstract][Full Text] [Related]
7. Inhibition of RNA Helicase Activity Prevents Coxsackievirus B3-Induced Myocarditis in Human iPS Cardiomyocytes.
Yun SH; Shin HH; Ju ES; Lee YJ; Lim BK; Jeon ES
Int J Mol Sci; 2020 Apr; 21(9):. PubMed ID: 32344926
[TBL] [Abstract][Full Text] [Related]
8. Astragaloside IV exerts antiviral effects against coxsackievirus B3 by upregulating interferon-gamma.
Zhang Y; Zhu H; Huang C; Cui X; Gao Y; Huang Y; Gong W; Zhao Y; Guo S
J Cardiovasc Pharmacol; 2006 Feb; 47(2):190-5. PubMed ID: 16495755
[TBL] [Abstract][Full Text] [Related]
9. Treatment of coxsackievirus-B3-infected BALB/c mice with the soluble coxsackie adenovirus receptor CAR4/7 aggravates cardiac injury.
Dörner A; Grunert HP; Lindig V; Chandrasekharan K; Fechner H; Knowlton KU; Isik A; Pauschinger M; Zeichhardt H; Schultheiss HP
J Mol Med (Berl); 2006 Oct; 84(10):842-51. PubMed ID: 16924471
[TBL] [Abstract][Full Text] [Related]
10. Regulatory effects of mammalian target of rapamycin-activated pathways in type I and II interferon signaling.
Kaur S; Lal L; Sassano A; Majchrzak-Kita B; Srikanth M; Baker DP; Petroulakis E; Hay N; Sonenberg N; Fish EN; Platanias LC
J Biol Chem; 2007 Jan; 282(3):1757-68. PubMed ID: 17114181
[TBL] [Abstract][Full Text] [Related]
11. TRIM21 Restricts Coxsackievirus B3 Replication, Cardiac and Pancreatic Injury via Interacting With MAVS and Positively Regulating IRF3-Mediated Type-I Interferon Production.
Liu H; Li M; Song Y; Xu W
Front Immunol; 2018; 9():2479. PubMed ID: 30410495
[TBL] [Abstract][Full Text] [Related]
12. Recombinant Mouse β-Defensin 3 Protects against Coxsackievirus B3-Induced Myocarditis in Mice.
Jiang Y; Zhu R; Luo L; Mu Q; Zhu Y; Luo H; Zou X; Shen X
Intervirology; 2015; 58(6):343-9. PubMed ID: 26829552
[TBL] [Abstract][Full Text] [Related]
13. [Rapamycin affects eIF- 4E expression in rat myocardial fibroblasts infected by Coxsackievirus B3].
Chen CY; Sun YN; Yang ZC; Long YQ
Zhongguo Dang Dai Er Ke Za Zhi; 2007 Dec; 9(6):587-90. PubMed ID: 18082048
[TBL] [Abstract][Full Text] [Related]
14. c-FLIP-Short reduces type I interferon production and increases viremia with coxsackievirus B3.
Buskiewicz IA; Koenig A; Roberts B; Russell J; Shi C; Lee SH; Jung JU; Huber SA; Budd RC
PLoS One; 2014; 9(5):e96156. PubMed ID: 24816846
[TBL] [Abstract][Full Text] [Related]
15. Caboxamycin Inhibits Heart Inflammation in a Coxsackievirus B3-Induced Myocarditis Mouse Model.
Kim HG; Hillman PF; Lee YJ; Jeon HE; Lim BK; Nam SJ
Viruses; 2024 Apr; 16(5):. PubMed ID: 38793559
[TBL] [Abstract][Full Text] [Related]
16. QiHong prevents death in coxsackievirus B3 induced murine myocarditis through inhibition of virus attachment and penetration.
Song X; Liu Z; Wang H; Xin Y; Wang X; Chen J; Shi Y; Zhang C; Hui R
Exp Biol Med (Maywood); 2007 Dec; 232(11):1441-8. PubMed ID: 18040068
[TBL] [Abstract][Full Text] [Related]
17. Berberine impairs coxsackievirus B3-induced myocarditis through the inhibition of virus replication and host pro-inflammatory response.
Dai Q; He X; Yu H; Bai Y; Jiang L; Sheng H; Peng J; Wang M; Yu J; Zhang K
J Med Virol; 2021 Jun; 93(6):3581-3589. PubMed ID: 33336842
[TBL] [Abstract][Full Text] [Related]
18. Oxymatrine provides protection against Coxsackievirus B3-induced myocarditis in BALB/c mice.
Jiang Y; Zhu Y; Mu Q; Luo H; Zhi Y; Shen X
Antiviral Res; 2017 May; 141():133-139. PubMed ID: 28115196
[TBL] [Abstract][Full Text] [Related]
19. Antiviral and myocyte protective effects of murine interferon-beta and -{alpha}2 in coxsackievirus B3-induced myocarditis and epicarditis in Balb/c mice.
Wang YX; da Cunha V; Vincelette J; White K; Velichko S; Xu Y; Gross C; Fitch RM; Halks-Miller M; Larsen BR; Yajima T; Knowlton KU; Vergona R; Sullivan ME; Croze E
Am J Physiol Heart Circ Physiol; 2007 Jul; 293(1):H69-76. PubMed ID: 17434974
[TBL] [Abstract][Full Text] [Related]
20. Phyllaemblicin B inhibits Coxsackie virus B3 induced apoptosis and myocarditis.
Wang YF; Wang XY; Ren Z; Qian CW; Li YC; Kaio K; Wang QD; Zhang Y; Zheng LY; Jiang JH; Yang CR; Liu Q; Zhang YJ; Wang YF
Antiviral Res; 2009 Nov; 84(2):150-8. PubMed ID: 19699238
[TBL] [Abstract][Full Text] [Related]
[Next] [New Search]
